News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

3M Health Care (MMM) and Greystone Pharmaceuticals, Inc. Announce License Agreement for Innovative Wound Care Technology


7/17/2008 9:52:05 AM

ST. PAUL, Minn.--(BUSINESS WIRE)--3M Health Care and Greystone Pharmaceuticals, Inc. today announce they have entered into an exclusive, worldwide license agreement for wound care products using Greystone’s patented PHI technology, a proprietary formulation that aids in the management of hard-to-heal wounds.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES